Previous Close | 92.69 |
Open | 92.91 |
Bid | 66.00 x 800 |
Ask | 100.00 x 900 |
Day's Range | 92.29 - 94.36 |
52 Week Range | 45.38 - 97.24 |
Volume | |
Avg. Volume | 708,198 |
Market Cap | 4.665B |
Beta (5Y Monthly) | 1.08 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.78 |
Earnings Date | May 01, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 103.82 |
Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
iDose TR uses Celanese's (CE) VitalDose EVA. It is approved following the completion of two pivotal trials which demonstrates safety and efficacy.